Cytomos
The future of cell analysis. Smarter, faster and more accurate
Work With Cytomos
About Cytomos
Cytomos Dielectric Spectroscopy (CDS™) connects your bioprocessing dots to make sense of the unseen and complete your biotechnology vision. This unique, full-stack, single-cell resolution analysis platform delivers label-free analytics that will revolutionise therapy, discovery and development.
Midlothian & East Lothian Business Awards Ceremony
Thomas Clayton, Sevi Giakoumelou, and Lindsay Fraser were delighted to attend the Midlothian & East Lothian Business Awards, organised by the Midlothian Chamber of Commerce.
The team was elated to receive an award in the "SME of the Year" category, recognising the collaborative work and progress achieved by team Cytomos over the past year.
In 2022, Cytomos secured £1.6m seed funding from existing investor Archangel Investors Limited, with participation from Scottish Enterprise and Old College Capital. This investment allowed the company to expand its technical development and personnel, growing from 7 employees to 12. Additionally, Cytomos recently received £0.5m in SMART grant funding from Innovate UK.
The company is gaining momentum and eagerly anticipates reaching the next level of progress, fostering team development, and enhancing their revolutionary technology for real-time, in-line cell analytics.
Cytomos awarded £500k from Innovate UK
Cytomos is thrilled to announce that they have received £500k in SMART grant funding from Innovate UK, following a successful £1.6m investment round. This funding will accelerate the development of their innovative Cytomos Dielectric Spectroscopy (CDS™) instrument, which enables real-time monitoring of cell manufacturing processes using label-free, scalable sensor technology. By overcoming challenges in the cell technology sector and providing in-line, continuous culture monitoring, Cytomos aims to improve efficiency, lower costs, and pave the way for affordable, personalised medicine. Innovate UK's support underscores their commitment to driving productivity and economic growth by backing transformative technologies in health and social care.
